BHC लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 19:17):

Stats
आज की मात्रा	64 551.00
औसत मात्रा	2.85M
बाजार मूल्य	3.21B
EPS	$0 ( 2024-02-22 )
अगली कमाई की तारीख	( $0.740 ) 2024-05-02
Last Dividend	$1.000 ( 2010-11-10 )
Next Dividend	$0 ( N/A )
P/E	-5.43
ATR14	$0.0160 (0.18%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-29	Paulson John	Buy	5 890	Common Shares, No Par Value
2024-03-29	Icahn Brett	Buy	3 122	Common Shares, No Par Value
2024-03-29	Robertson Russel C	Buy	2 945	Common Shares, No Par Value
2024-03-29	Wechsler Amy B	Buy	647	Common Shares, No Par Value
2024-02-29	Barresi John S	Buy	39 126	Common Shares, No Par Value

INSIDER POWER
67.94
Last 100 transactions
Buy: 2 132 507 \| Sell: 336 154

मात्रा सहसंबंध

लंबा: -0.12 (neutral)

छोटा: 1.00 (very strong)

Signal:(57.036) Expect same movement, but be aware

Bausch Health Companies सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
YSAC	0.851
PKE	0.81

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Bausch Health Companies सहसंबंध - मुद्रा/वस्त्र

0.22
( neutral )

-0.01
( neutral )

0.00
( neutral )

-0.23
( neutral )

0.51
( weak )

-0.06
( neutral )

Bausch Health Companies वित्तीय

Annual	2023
राजस्व:	$8.76B
सकल लाभ:	$6.20B (70.78 %)
EPS:	$-1.620

FY	2023
राजस्व:	$8.76B
सकल लाभ:	$6.20B (70.78 %)
EPS:	$-1.620

FY	2022
राजस्व:	$8.12B
सकल लाभ:	$5.76B (70.90 %)
EPS:	$-0.590

FY	2021
राजस्व:	$8.43B
सकल लाभ:	$6.04B (71.61 %)
EPS:	$-2.67

Financial Reports:

No articles found.

Bausch Health Companies Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Bausch Health Companies Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 6.11 - average (70.51%) | Divividend Growth Potential Score: 2.84 - No dividend growth expected in the near future

Information

First Dividend	$0.500	2005-11-28
Last Dividend	$1.000	2010-11-10
Next Dividend	$0	N/A
Payout Date	2010-12-22
Next Payout Date	N/A
# dividends	22	--
Total Paid Out	$6.43	--
Avg. Dividend % Per Year	0.00%	--
Score	3.06	--
Div. Sustainability Score	6.11
Div.Growth Potential Score	2.84
Div. Directional Score	4.48	--

Next Divdend (Est)
(2024-06-07)

$0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

3.06

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2005	$0.500	3.07%
2006	$0.500	2.01%
2007	$2.00	9.47%
2008	$1.500	11.20%
2009	$0.645	6.68%
2010	$1.280	8.72%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
NCZ	Dividend Royal	2024-02-09	Monthly	22	7.79%	8.50
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50
SJT	Dividend Royal	2023-11-29	Monthly	39	12.52%	8.50
GOF	Dividend Royal	2023-11-14	Monthly	18	8.03%	8.50
SRV	Dividend Royal	2023-12-04	Monthly	18	7.53%	8.50
VGI	Dividend Royal	2024-02-09	Monthly	13	7.36%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0190	1.500	-0.379	-0.569	[0 - 0.5]
returnOnAssetsTTM	-0.00607	1.200	-0.202	-0.243	[0 - 0.3]
returnOnEquityTTM	0.171	1.500	9.21	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.301	0.800	8.50	6.80	[1 - 3]
quickRatioTTM	0.685	0.800	-0.679	-0.543	[0.8 - 2.5]
cashRatioTTM	0.220	1.500	9.89	10.00	[0.2 - 2]
debtRatioTTM	0.819	-1.500	10.00	-10.00	[0 - 0.6]
interestCoverageTTM	-0.725	1.000	-1.380	-1.380	[3 - 30]
operatingCashFlowPerShareTTM	3.00	2.00	9.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	2.23	2.00	8.89	10.00	[0 - 20]
debtEquityRatioTTM	-21.91	-1.500	-10.00	10.00	[0 - 2.5]
grossProfitMarginTTM	0.995	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.110	1.000	9.80	9.80	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.0489	1.000	-0.839	-0.839	[0.2 - 2]
assetTurnoverTTM	0.320	0.800	-1.199	-0.959	[0.5 - 2]
Total Score				6.11

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-19.16	1.000	-2.04	0	[1 - 100]
returnOnEquityTTM	0.171	2.50	9.49	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	2.23	2.00	9.26	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.00	2.00	9.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.390	1.500	-5.93	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.125	1.000	9.37	0	[0.1 - 0.5]
Total Score				2.84

Bausch Health Companies

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

के लिए वास्तविक समय के अद्यतन Bausch Health Companies [BHC]

Upcoming Earnings Alert

Bausch Health Companies Dividend Information - Ex Dividend Knight

Dividend Commentary

Top 10 dividend Companies for NYSE

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)